Glenmark Speclt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK SPECLT, and when can generic versions of GLENMARK SPECLT drugs launch?
GLENMARK SPECLT has twenty-seven approved drugs.
There are fifteen US patents protecting GLENMARK SPECLT drugs.
There are eighty-two patent family members on GLENMARK SPECLT drugs in thirty-three countries and ninety-two supplementary protection certificates in fifteen countries.
Summary for Glenmark Speclt
| International Patents: | 82 |
| US Patents: | 15 |
| Tradenames: | 23 |
| Ingredients: | 22 |
| NDAs: | 27 |
Drugs and US Patents for Glenmark Speclt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 202894-001 | Oct 30, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 079172-002 | Jul 19, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 079172-001 | Jul 19, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 206391-002 | Sep 19, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | CLOBETASOL PROPIONATE | clobetasol propionate | CREAM;TOPICAL | 209095-001 | May 10, 2018 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209663-001 | Nov 15, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 079172-003 | Jul 19, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Glenmark Speclt Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 111787954 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2015049665 | ⤷ Sign Up |
| South Korea | 20200023599 | ⤷ Sign Up |
| Japan | 6768733 | ⤷ Sign Up |
| China | 109475495 | ⤷ Sign Up |
| Mexico | 2015013965 | ⤷ Sign Up |
| South Korea | 20200125625 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Glenmark Speclt Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0914118 | PA2007001 | Lithuania | ⤷ Sign Up | PRODUCT NAME: DEFERASIROXUM; REGISTRATION NO/DATE: EU/1/06/356/001 2006 08 28, EU/1/06/356/002 2006 08 28, EU/1/06/356/003 2006 08 28, EU/1/06/356/004 2006 08 28, EU/1/06/356/005 2006 08 28, EU/1/06/356/00 20060828 |
| 2435024 | 301102 | Netherlands | ⤷ Sign Up | PRODUCT NAME: COMBINATIE VAN FORMOTEROL (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN), GLYCOPYRROLAAT (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN) EN BUDESONIDE (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN); REGISTRATION NO/DATE: EU/1/20/1498 20201210 |
| 0521471 | 0390023-0 | Sweden | ⤷ Sign Up | PRODUCT NAME: ROSUVASTATIN |
| 2435024 | SPC/GB21/029 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF FORMOTEROL, INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS AND SOLVATES THEREOF, GLYCOPYRROLATE, INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS AND SOLVATES THEREOF, AND BUDESONIDE INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ES; REGISTERED: UK EU/1/20/1498 (NI) 20201210; UK PLGB 17901/0352-001 20201210 |
| 0521471 | 0391023-9 | Sweden | ⤷ Sign Up | PRODUCT NAME: ROSUVASTATIN |
| 0771217 | CA 2006 00038 | Denmark | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804 |
| 0734381 | 3/2004 | Austria | ⤷ Sign Up | PRODUCT NAME: APREPITANT, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEMBAREN SALZES; REGISTRATION NO/DATE: EU/1/03/262/001 - EU/1/03/262/006 20031111 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
